Therefore, 2H9 was further developed into an antibody-drug conjugate (ADC) to monomethylauristatin E and showed the antitumor efficacy to EphB2-overexpressed fibrosarcoma HT1080 and colorectal cancer xenografts [25]. Here, EPHB2 is linked to colorectal cancer.